Indoco Remedies Limited (NSE:INDOCO)
India · Delayed Price · Currency is INR 223.70
-1.90 (-0.84%)
Oct 23, 2026, 2:34 PM IST
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 20.65 billion as of October 22, 2026. It is the 20,056th most valuable company in the world and the 1,213th biggest in India. Its market cap has decreased by 22.23% in one year.
Market Cap
20.65B
Enterprise Value
31.14B
Revenue
18.73B
Global Rank
Country Rank
#1,213 India
PE Ratio
354.15
ChartMarket Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 20.65B, an increase of 343.09%. That is a compound annual growth rate of 7.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 20.65B | -4.59% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 47.02B |
| Orchid Pharma | 45.32B |
| Solara Active Pharma Sciences | 31.15B |
| Ind-Swift Laboratories | 30.60B |
| Sakar Healthcare | 20.54B |
| Windlas Biotech | 18.70B |
| Beta Drugs | 17.43B |
| Jagsonpal Pharmaceuticals | 14.35B |